A Survey of Risk Tolerance to Multiple Sclerosis Therapies

NARCOMS, the CMSC Patient Registry, is led by a team of world-renowned MS clinicians and researchers.  Date from NARCOMS has provided the MS community with a treasure trove of new information about MS.  This article reflects outcomes of a study looking at a person’s ability to tolerate risk when considering choices of disease modifying therapy in partnership with his or her prescriber.  Kudos to the NARCOMS team for once again publishing new and exciting information.